EDAP closes direct offering

|About: EDAP TMS S.A. (EDAP)|By:, SA News Editor

French biotech EDAP (EDAP +14.4%) closes a $9.3M direct offering of ordinary shares at $3.11/ADS. Proceeds will be used to advance the preparatory activities related to the Ablatherm HIFU PMA and upcoming Gastroenterology and Urology Devices Ad Comm meeting on July 30 and to expand its U.S. operations to promote Ablatherm HIFU post approval. The device was CE Mark-approved in 2000.